Pathfinder

Conventional Peptide Synthesis vs. Recombinant Peptide Production: Which Manufacturing Strategy Is Better?

Nice Insight

U.S. CDMO Capacity

More Than Capacity: What the Latest U.S. CDMO Expansion Wave Reveals About Specialized Manufacturing Demand

Pharma's Almanac

Peptides

Enabling the Commercialization of Peptide Therapeutics with Manufacturing Advances

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Peptide Production

Peptide Manufacturing Enters the Industrial Era

David Alvaro, Ph.D.

Pharma's Almanac

Peptides

The Resurgence of Peptide Drugs in the Age of Precision Medicine

David Alvaro, Ph.D.

Pharma's Almanac

Greener TIDES

Greener Pathways for Peptide and Oligonucleotide Manufacturing

David Alvaro, Ph.D.

Pharma's Almanac